The plot has thickened. If that is the case I wonder how long GCAN sticks around with Symtomax. It seems to be the only donkey we have hitched our cart too.
Found this that was put on Linkedin 2 hours ago by Chairman of Symptomax Paul Segal who is linked to 2 people I know in CBD industry one is a PhD... he also has over 5,600 links so is no lightweight...
Details flavors, launch, and direct to consumer.. plus hiring another expert in public financing